ASCO Review- 2015 What is new in breast cancer?
Therapeutic antibodies 5_humanization
Phase II Trial of Gemcitabine and Docetaxel With Bevacizumab in Soft Tissue Sarcoma
An Oncology Exchange Activity Prior to the start of the program, please check your syllabus to ensure you have the following printed program materials:
Role of Vascular Endothelial Growth Factor (VEGF) in CRPC
Giorgio Mustacchi NSCLC: Targeting angiogenesis. NON-SMALL CELL LUNG CANCER.
Current Opinion in the Colorectal Cancer Treatment Dott. Carlo Garufi Oncologia Medica C Istituto Regina Elena – Roma [email protected].
AVADO
Final Overall Survival Results, Including Analysis of Patients with Triple-Negative Disease and Aged ≥70 Years, from the Athena Study Evaluating First-Line.
AVADO TRIAL David Miles Mount Vernon Cancer Centre, Middlesex, United Kingdom A randomized, double-blind study of bevacizumab in combination with docetaxel.
FOLFOX4 with or without Bevacizumab in Previously Treated Advanced Colorectal Cancer: Results from ECOG-E3200 Lee M Ellis, MD Colorectal Cancer Update.
TAP Vol 1 Issue 4